205 related articles for article (PubMed ID: 3313681)
1. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S
Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-resistant Shigella and enterotoxigenic Escherichia coli strains in children in Thailand.
Chatkaeomorakot A; Echeverria P; Taylor DN; Seriwatana J; Leksomboon U
Pediatr Infect Dis J; 1987 Aug; 6(8):735-9. PubMed ID: 3313233
[TBL] [Abstract][Full Text] [Related]
3. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.
Hoge CW; Gambel JM; Srijan A; Pitarangsi C; Echeverria P
Clin Infect Dis; 1998 Feb; 26(2):341-5. PubMed ID: 9502453
[TBL] [Abstract][Full Text] [Related]
4. Current problems in antimicrobial therapy for bacterial enteric infection.
DuPont HL; Ericsson CD; Robinson A; Johnson PC
Am J Med; 1987 Apr; 82(4A):324-8. PubMed ID: 3555056
[TBL] [Abstract][Full Text] [Related]
5. Diarrheagenic Escherichia coli and Shigella with High Rate of Extended-Spectrum Beta-Lactamase Production: Two Predominant Etiological Agents of Acute Diarrhea in Shiraz, Iran.
Aminshahidi M; Arastehfar A; Pouladfar G; Arman E; Fani F
Microb Drug Resist; 2017 Dec; 23(8):1037-1044. PubMed ID: 29106325
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.
Hopkins KL; Mushtaq S; Richardson JF; Doumith M; de Pinna E; Cheasty T; Wain J; Livermore DM; Woodford N
Int J Antimicrob Agents; 2014 May; 43(5):431-7. PubMed ID: 24661532
[TBL] [Abstract][Full Text] [Related]
7. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico.
Bandres JC; Mathewson JJ; Ericsson CD; Dupont HL
Am J Med Sci; 1992 May; 303(5):289-91. PubMed ID: 1580315
[TBL] [Abstract][Full Text] [Related]
9. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
[TBL] [Abstract][Full Text] [Related]
10. Microbiological perspectives of co-trimoxazole.
Bauernfeind A; Hörl G; Przyklenk B
Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
[TBL] [Abstract][Full Text] [Related]
11. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.
Nguyen TV; Le PV; Le CH; Weintraub A
Antimicrob Agents Chemother; 2005 Feb; 49(2):816-9. PubMed ID: 15673777
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
Ericsson CD; Johnson PC; Dupont HL; Morgan DR; Bitsura JA; de la Cabada FJ
Ann Intern Med; 1987 Feb; 106(2):216-20. PubMed ID: 3541724
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
[TBL] [Abstract][Full Text] [Related]
15. Multiresistant strains of enteric pathogens cultured from stools of acute cases of diarrhea in Cairo, Egypt.
Bassily S; Mikhail I; Abdel-Malek B; el-Masry N; Lissner CR
Chemioterapia; 1987 Jun; 6(2 Suppl):31-2. PubMed ID: 3509426
[No Abstract] [Full Text] [Related]
16. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt.
Wasfy MO; Oyofo BA; David JC; Ismail TF; el-Gendy AM; Mohran ZS; Sultan Y; Peruski LF
J Health Popul Nutr; 2000 Jun; 18(1):33-8. PubMed ID: 11014768
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000.
Putnam SD; Riddle MS; Wierzba TF; Pittner BT; Elyazeed RA; El-Gendy A; Rao MR; Clemens JD; Frenck RW
Clin Microbiol Infect; 2004 Sep; 10(9):804-10. PubMed ID: 15355411
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from Mozambique.
Hlashwayo DF; Noormahomed EV; Bahule L; Benson CA; Schooley RT; Sigaúque B; Barrett KE; Bila CG
BMC Infect Dis; 2023 Apr; 23(1):255. PubMed ID: 37085752
[TBL] [Abstract][Full Text] [Related]
19. Etiology of travellers' diarrhea.
Jiang ZD; DuPont HL
J Travel Med; 2017 Apr; 24(suppl_1):S13-S16. PubMed ID: 28521001
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea.
Inagaki Y; Horiuchi S; Une T; Nakaya R
J Antimicrob Chemother; 1989 Oct; 24(4):547-9. PubMed ID: 2613604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
